PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
31-Mar-2020 Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy Heidelberg Pharma AG
31-Mar-2020 Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group Clarity Pharmaceuticals
30-Mar-2020 MindMed Reports Year-end Results and Corporate Update Mind Medicine (MindMed) Inc.
30-Mar-2020 Imfinzi approved in the US for extensive-stage small cell lung cancer AstraZeneca
30-Mar-2020 Abeona Therapeutics Stakeholder Letter in Response to the COVID-19 Pandemic Abeona Therapeutics
30-Mar-2020 Faron Pharmaceuticals Oy: Completion of Part 1 dose finding stage of the MATINS Phase I/II Study Faron Pharmaceuticals Ltd
30-Mar-2020 Epigenomics AG decides to increase share capital by way of private placement Epigenomics AG
30-Mar-2020 Resaphene Suisse AG: Resaphene Suisse AG has applied for delisting at the Vienna Stock Exchange Resaphene Suisse AG
30-Mar-2020 Biotest AG: Biotest exceeds EBIT forecast in the 2019 financial year Biotest AG
30-Mar-2020 Coronavirus (COVID-19) Update: FDA expedites review of diagnostic tests to combat COVID-19 U.S. Food and Drug Administration
30-Mar-2020 Rapid Nutrition PLC: Half Year Results - Well Ahead of Expectations Rapid Nutrition PLC
30-Mar-2020 Intas Contributes for the Global Trials Against COVID19 Intas Pharmaceuticals Ltd
30-Mar-2020 Fresenius Medical Care AG & Co. KGaA postpones 2020 Annual General Meeting Fresenius Medical Care AG & Co. KGaA
30-Mar-2020 New analysis confirms value of investing public money to commercialise public science Sciad Newswire
30-Mar-2020 Polyphor announces positive Data Safety Monitoring Board (DSMB) recommendation to continue Phase III FORTRESS study without modifications Polyphor AG
30-Mar-2020 CSPC Pharmaceutical Announces 2019 Annual Results CSPC Pharmaceutical Group Limited
30-Mar-2020 Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development Ascentage Pharma
28-Mar-2020 Coronavirus (COVID-19) Update: FDA takes further steps to help mitigate supply interruptions of food and medical products U.S. Food and Drug Administration
28-Mar-2020 Ryvu Therapeutics Receives Orphan Drug Designation From FDA for SEL120 to Treat Acute Myeloid Leukemia Ryvu Therapeutics
28-Mar-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration